Clinical Trial Update: Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial to assess how a hemp product influences the pharmacokinetics and pharmacodynamics of clopidogrel; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Infarction
• Peripheral Arterial Disease
• Stroke
• Transient Ischemic Attack
• Unstable Angina

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Washington State University | Conditions: Interaction | EARLY_Phase 1 | Status: RECRUITING